D.E. Shaw & Co’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-26,883
| Closed | -$98K | – | 4543 |
|
|
2021
Q4 | $98K | Sell |
26,883
-9,379
| -26% | -$34.2K | ﹤0.01% | 3662 |
|
|
2021
Q3 | $291K | Buy |
+36,262
| New | +$291K | ﹤0.01% | 3073 |
|
|
2017
Q2 | – | Sell |
-854
| Closed | -$123K | – | 2604 |
|
|
2017
Q1 | $123K | Buy |
854
+163
| +24% | +$23.5K | ﹤0.01% | 2330 |
|
|
2016
Q4 | $87K | Buy |
691
+223
| +48% | +$28.1K | ﹤0.01% | 2416 |
|
|
2016
Q3 | $72K | Sell |
468
-631
| -57% | -$97.1K | ﹤0.01% | 2434 |
|
|
2016
Q2 | $126K | Sell |
1,099
-20
| -2% | -$2.29K | ﹤0.01% | 2423 |
|
|
2016
Q1 | $126K | Sell |
1,119
-7
| -0.6% | -$788 | ﹤0.01% | 2457 |
|
|
2015
Q4 | $212K | Buy |
1,126
+732
| +186% | +$138K | ﹤0.01% | 2412 |
|
|
2015
Q3 | $67K | Sell |
394
-2,107
| -84% | -$358K | ﹤0.01% | 2481 |
|
|
2015
Q2 | $1.58M | Sell |
2,501
-43
| -2% | -$27.2K | ﹤0.01% | 1609 |
|
|
2015
Q1 | $1.31M | Sell |
2,544
-1,098
| -30% | -$565K | ﹤0.01% | 1590 |
|
|
2014
Q4 | $1.95M | Buy |
3,642
+3,579
| +5,681% | +$1.92M | ﹤0.01% | 1373 |
|
|
2014
Q3 | $94K | Sell |
63
-1,005
| -94% | -$1.5M | ﹤0.01% | 2280 |
|
|
2014
Q2 | $1.46M | Sell |
1,068
-257
| -19% | -$352K | ﹤0.01% | 1397 |
|
|
2014
Q1 | $1.84M | Sell |
1,325
-1,341
| -50% | -$1.86M | ﹤0.01% | 1296 |
|
|
2013
Q4 | $2.65M | Buy |
2,666
+1,267
| +91% | +$1.26M | ﹤0.01% | 1151 |
|
|
2013
Q3 | $1.46M | Buy |
1,399
+1,096
| +362% | +$1.14M | ﹤0.01% | 1391 |
|
|
2013
Q2 | $332K | Buy |
+303
| New | +$332K | ﹤0.01% | 1992 |
|